FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Niranjan Pandey

Research Profile

Chemicals & Drugs

Anatomy

Concepts & Ideas

Structure-Activity Relationship

Physiology

Occupations

Drug Design

Living Beings

Rats

Co-author Network

Publications

TOP 3
Esak Lee; Niranjan Pandey; Jacob E Koskimaki; Aleksander S Popel
Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.
Jacob E Koskimaki; Esak Lee; Niranjan Pandey; Corban G Rivera; Elena V Rosca; William Chen; Aleksander S Popel
Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.
Elena V Rosca; Amir P Tamiz; Jacob E Koskimaki; Niranjan Pandey; Aleksander S Popel
Structure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptides.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Niranjan Pandey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Esak Lee; Niranjan Pandey; Jacob E Koskimaki; Aleksander S Popel
Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.
Neoplasia (New York, N.Y.) 2013;15(2):112-24.
2013: Jacob E Koskimaki; Esak Lee; Niranjan Pandey; Corban G Rivera; Elena V Rosca; William Chen; Aleksander S Popel
Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.
Angiogenesis 2013;16(1):159-70.
2012: Elena V Rosca; Amir P Tamiz; Jacob E Koskimaki; Niranjan Pandey; Aleksander S Popel
Structure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptides.
Chemical biology & drug design 2012;80(1):27-37.
2012: Shobha Gopalakrishnan; Amir P Tamiz; Amit Tripathi; Sefik S Alkan; Niranjan Pandey
Larazotide acetate promotes tight junction assembly in epithelial cells.
Peptides 2012;35(1):95-101.
2012: Shobha Gopalakrishnan; Kelly Kitchens; Joseph A Murray; Blake M Paterson; Robert Somerville; Amir P Tamiz; Elena F Verdu; Sefik S Alkan; Malarvizhi Durai; Mark Ginski; Niranjan Pandey
Larazotide acetate regulates epithelial tight junctions in vitro and in vivo.
Peptides 2012;35(1):86-94.
2012: Jacob E Koskimaki; Esak Lee; Niranjan Pandey; Corban G Rivera; Elena V Rosca; William Chen; Aleksander S Popel
Serpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growth.
Translational oncology 2012;5(2):92-7.
2011: Esak Lee; Niranjan Pandey; Elena V Rosca; Aleksander S Popel
Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.
The international journal of biochemistry & cell biology 2011;43(12):1812-21.
2011: Elena V Rosca; Antonio C Wolff; Jacob E Koskimaki; Niranjan Pandey; Aleksander S Popel
Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.
Cancer biology & therapy 2011;12(9):808-17.
2011: Corban G Rivera; Elena V Rosca; Joel S Bader; Jacob E Koskimaki; Niranjan Pandey; Aleksander S Popel
Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.
Journal of medicinal chemistry 2011;54(19):6492-500.
2011: Elena V Rosca; Amir P Tamiz; Jacob E Koskimaki; Niranjan Pandey; Corban G Rivera; Aleksander S Popel
Anti-angiogenic peptides for cancer therapeutics.
Current pharmaceutical biotechnology 2011;12(8):1101-16.
2009: Ronghui Lin; Sigmond G Johnson; Peter J Connolly; Steven K Wetter; Eva Binnun; Terry V Hughes; William V Murray; Niranjan Pandey; Sandra J Moreno-Mazza; Mary Adams; Angel Fuentes-Pesquera; Steven A Middleton
Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
Bioorganic & medicinal chemistry letters 2009;19(8):2333-7.
2009: Shobha Gopalakrishnan; Niranjan Pandey; Amir P Tamiz; John Vere; Rosa Carrasco; Robert Somerville; Amit Tripathi; Mark Ginski; Blake M Paterson; Sefik Alkan
Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer.
International journal of pharmaceutics 2009;365(1-2):121-30.
2008: Terry V Hughes; Guozhang Xu; Steven K Wetter; Peter J Connolly; Stuart Emanuel; Prabha Karnachi; Scott R Pollack; Niranjan Pandey; Mary Adams; Sandra Moreno-Mazza; Steven A Middleton; Lee M Greenberger
A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: design, synthesis, and biological activity.
Bioorganic & medicinal chemistry letters 2008;18(17):4896-9.
2008: Guozhang Xu; Marta C Abad; Peter J Connolly; Michael P Neeper; Geoffrey T Struble; Barry A Springer; Stuart Emanuel; Niranjan Pandey; Robert H Gruninger; Mary Adams; Sandra Moreno-Mazza; Angel Fuentes-Pesquera; Steven A Middleton
4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors.
Bioorganic & medicinal chemistry letters 2008;18(16):4615-9.
2008: Guozhang Xu; Lily Lee Searle; Terry V Hughes; Amanda K Beck; Peter J Connolly; Marta C Abad; Michael P Neeper; Geoffrey T Struble; Barry A Springer; Stuart Emanuel; Robert H Gruninger; Niranjan Pandey; Mary Adams; Sandra Moreno-Mazza; Angel Fuentes-Pesquera; Steven A Middleton; Lee M Greenberger
Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases.
Bioorganic & medicinal chemistry letters 2008;18(12):3495-9.
2008: Stuart Emanuel; Terry V Hughes; Mary Adams; Catherine A Rugg; Angel Fuentes-Pesquera; Peter J Connolly; Niranjan Pandey; Sandra Moreno-Mazza; Jeannene Butler; Virna Borowski; Steven A Middleton; Robert H Gruninger; Jennifer R Story; Cheryl Napier; Beth Hollister; Lee M Greenberger
Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
Molecular pharmacology 2008;73(2):338-48.
2005: Ronghui Lin; Yanhua Lu; Steven K Wetter; Peter J Connolly; Ignatius Turchi; William V Murray; Stuart Emanuel; Robert H Gruninger; Angel Fuentes-Pesquera; Mary Adams; Niranjan Pandey; Sandra Moreno-Mazza; Steven A Middleton; Linda Jolliffe
3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
Bioorganic & medicinal chemistry letters 2005;15(9):2221-4.